课题基金 / 基金详情

Newly Gene Therapy Targeting Inhibition of the Tumor Angiogenesis Using Decoy System

Newly Gene Therapy Targeting Inhibition of the Tumor Angiogenesis Using Decoy System
利用诱饵系统抑制肿瘤血管生成的新基因疗法
批准号:
16390539
负责人:
ISHIBASHI Hiroaki
金额:
$9.02万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2006

项目摘要

项目成果

ISHIBASHI Hiroaki的其他基金

相似基金

相关文献

中文摘要
翻译
从周围组织的正常微血管系统发展而来的新的毛细血管网络被认为对实体肿瘤的生长起着关键作用。肿瘤细胞通过刺激内皮细胞产生多种血管生成因子来影响血管生成。其中,血管内皮生长因子(VEGF)是最强的血管生成因子之一,也是内皮细胞特异性的丝裂原。先前的一些研究表明,在体内和体外模型中,使用反义寡核苷酸或中和抗体抑制血管内皮生长因子可抑制肿瘤生长。众所周知,血管内皮生长因子是低氧诱导的,最近有报道称,通过转录因子Sp1与血管内皮生长因子启动子结合,在肿瘤坏死因子α刺激下合成血管内皮生长因子α。我们推测,将合成的含有Sp1结合位点共同序列的双链DNA作为顺反向元件诱饵导入肿瘤细胞核,可以阻断Sp1与血管内皮生长因子启动子基因的结合。野生型Sp1诱骗和突变型诱骗对肿瘤坏死因子α刺激的培养的人癌细胞血管内皮生长因子合成有显著的抑制作用。这种Sp1诱骗导入肿瘤细胞可能是一种新的有效的治疗工具,通过抑制血管内皮生长因子的合成来诱导肿瘤休眠。此外,转移Sp1诱饵比转移反义寡核苷酸更有效地调控肿瘤的生长和侵袭,因为并不是所有的血管生成因子都能被同时抑制,而且Sp1调控的生长和侵袭相关因子的表达也可以同时被抑制。
英文摘要
The development of newly capillary networks from the normal microvasculature of the surrounding tissue has thought to play a critical role for the growth of the solid tumors. Tumor cells influence the angiogenesis by stimulation of endothelial cells with producing several angiogenic factors. Among them, vascular endothelial growth factor (VEGF) is one of the most potent angiogenic factors, and endothelial cell specific mitogen. Several previous studies suggested that inhibition of VEGF using antisense oligodeoxynucleotides or neutralizing antibodies against VEGF suppressed tumor growth in various in vivo and in vitro models. VEGF is well known to be hypoxia-inducible, and has been recently reported to be synthesized by stimulation with tumor necrosis factor α (TNFα) via binding of transcription factor Sp1 to the VEGF promoter. We hypothesized that transfection into the tumor cells nucleus of the synthetic double stranded DNA including consensus sequence of binding site of the Sp1 as cis-trans element decoy could block the binding of Sp1 to the VEGF promoter gene. Transfection of wild type Sp1 decoy, but mutant type decoy, revealed prominent inhibitory effects of VEGF synthesis of cultured human carcinoma cells stimulated by TNFα. This Sp1 decoy introduction into tumor cells may be a novel and useful therapeutic tool for induction of tumor dormancy by its inhibitory effect on VEGF synthesis. In addition, the transfer of the Sp1 decoy would be more effective for regulating tumor growth and invasion than that of antisense oligonucleotide, since not all angiogenic factors but also growth and invasion related factors expression modulated by Sp1 could be simultaneously suppressed.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
Inhibition of vascular endothelial growth factor (VEGF) In oral cancer cells by HIF-1 decoy
HIF-1 诱饵抑制口腔癌细胞中的血管内皮生长因子 (VEGF)
DOI: --
发表时间: 2005
期刊: J Jpn Stomatol Soc 54(1)
影响因子: --
作者: [Imai, M, Ishibashi, H, et. al.]
通讯作者: et. al.
Expression of tumor-associated RCASI and its possible involvement in immune evasion in oral squamous cell carcinoma
口腔鳞状细胞癌肿瘤相关RCASI的表达及其参与免疫逃避的可能
DOI: --
发表时间: 2006
期刊: J Oral Pathol Med 3
影响因子: --
作者: [Toyoshima, T., Nakamura, S., Kumamaru, W., Kawamura, E., Ishibashi, H., et al.]
通讯作者: et al.
The Association between the Computed Tonography Findings.
计算机断层扫描结果之间的关联。
DOI: --
发表时间: 2005
期刊: J Oral Maxillofac Surg 63
影响因子: --
作者: [Nakayama E, Sugiura T, Kobayashi I, Ishibashi H, et al.]
通讯作者: et al.
Severity of oral mucositis correlates with the response of oral cancer to preoperative radiochemotherapy.
口腔粘膜炎的严重程度与口腔癌对术前放化疗的反应相关。
DOI: --
发表时间: 2005
期刊: Int J Oral Maxillofac Surg 34
影响因子: --
作者: [Ikebe, T., K.Seki, et al.]
通讯作者: et al.
共 10 条
    Simple Domestic Gene Therapy against Anti-cancer Angiogenesis with Decoy Oligonucleotides.
    Newky gene therapy using decoy system for degenerative arthritis
    THE DEVELOPMENT OF NEWLY JAPAN-ORIGINAL GENE THERAPY FOR DEGENERATIVE ARTHROSIS USING DECOY GENE.
    • 批准号:
      21659433
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.09万
    • 财政年份:
      2009
    • 负责人:
      ISHIBASHI Hiroaki
    • 依托单位:
    THE ESTABLISHMENT OF JAPAN-ORIGINAL GENE THERAPY BY ANTI-TUMOR ANGIOGENESIS USING DECOY GENE.
    • 批准号:
      20390478
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.06万
    • 财政年份:
      2008
    • 负责人:
      ISHIBASHI Hiroaki
    • 依托单位:
    国内基金
    海外基金
    ROBO4对视网膜血管生成(angiogenesis)的调控及其分子机制
    • 批准号:
      81200692
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      23.0万元
    • 批准年份:
      2012
    • 负责人:
      陈凌
    • 依托单位: